Stay updated on Isatuximab Safety, PK, and Efficacy in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Isatuximab Safety, PK, and Efficacy in Multiple Myeloma Clinical Trial page.

Latest updates to the Isatuximab Safety, PK, and Efficacy in Multiple Myeloma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA new Revision: v3.6.6 appears in the footer and the previous Revision: v3.6.5 is removed, indicating a page revision update to the study history interface.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedThe revision history gains a new version label v3.6.5, indicating an updated page revision. The older v3.6.4 entry is removed from the current view.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page's footer now displays Revision: v3.6.4, replacing the previous Revision: v3.6.3, indicating a site version update. This does not alter any study information or how the page functions.SummaryDifference0.1%

- Check69 days agoChange DetectedA new revision entry v3.6.3 was added to the record history, and the prior revision v3.6.2 was removed from the current listing. This indicates the study record has progressed to a newer revision in the history.SummaryDifference0.1%

- Check75 days agoChange DetectedThe revision history adds a new entry for Revision: v3.6.2 and removes Revision: v3.6.0, indicating a small behind-the-scenes update to the page rendering.SummaryDifference0.1%

- Check90 days agoChange DetectedThe history now shows recruitment is no longer looking for participants, indicating the study is not enrolling at this time. It also adds the latest revision tag v3.6.0 and removes the previous revision v3.5.5.SummaryDifference0.2%

Stay in the know with updates to Isatuximab Safety, PK, and Efficacy in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Isatuximab Safety, PK, and Efficacy in Multiple Myeloma Clinical Trial page.